Beck Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,004
| Closed | -$932K | – | 130 |
|
|
2024
Q3 | $932K | Buy |
2,004
+38
| +2% | +$17.7K | 0.25% | 89 |
|
|
2024
Q2 | $922K | Buy |
1,966
+79
| +4% | +$37K | 0.25% | 86 |
|
|
2024
Q1 | $789K | Buy |
1,887
+3
| +0.2% | +$1.25K | 0.23% | 89 |
|
|
2023
Q4 | $767K | Sell |
1,884
-7
| -0.4% | -$2.85K | 0.26% | 88 |
|
|
2023
Q3 | $658K | Buy |
1,891
+21
| +1% | +$7.3K | 0.25% | 85 |
|
|
2023
Q2 | $658K | Sell |
1,870
-227
| -11% | -$79.9K | 0.26% | 87 |
|
|
2023
Q1 | $661K | Sell |
2,097
-132
| -6% | -$41.6K | 0.28% | 97 |
|
|
2022
Q4 | $644K | Sell |
2,229
-52
| -2% | -$15K | 0.27% | 106 |
|
|
2022
Q3 | $660K | Buy |
2,281
+43
| +2% | +$12.4K | 0.28% | 106 |
|
|
2022
Q2 | $631K | Buy |
+2,238
| New | +$631K | 0.28% | 98 |
|